Lisdexamfetamine maintenance treatment for binge-eating disorder following successful treatments: randomized double-blind placebo-controlled trial
Adults with BED/obesity who respond to acute lisdexamfetamine treatment (regardless of additionally receiving CBT) had good maintenance during subsequent 12-weeks. Maintenance lisdexamfetamine, relative to placebo, did not provide further benefit for binge-eating but was associated with significantly better eating-disorder psychopathology outcomes and greater weight-loss.
Authors
- Ashley A. Wiedemann (ORCID: https://orcid.org/0000-0002-4918-7502)
- Sydney Yurkow (ORCID: https://orcid.org/0000-0003-3569-4666)
- Cenk Tek (ORCID: https://orcid.org/0000-0002-3439-1914)
- Ralitza Gueorguieva (ORCID: https://orcid.org/0000-0003-0944-5973)
- Valentina Ivezaj (ORCID: https://orcid.org/0000-0001-8760-8040)
- Carlos M. Grilo (ORCID: https://orcid.org/0000-0003-0245-3444)
Institutions
- Yale University (US)
Publication Details
- Journal
- Psychological Medicine
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1017/s003329172400148x
- Citations
- 9
- Primary Topic
- Eating Disorders and Behaviors
- Type
- article
- Field-Weighted Citation Impact
- 5.75